New Jersey Headlines

Grand View Research, Inc. – Market Research And Consulting.

According to a report, “Transplantation Market By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solutions), By Application (Organ, Tissue Transplantation), By End-use, And Segment Forecasts, 2018 – 2025″.published by Grand View Research, Inc., The global transplantation market is expected to reach USD 51.0 billion by the year 2025, growing at a CAGR of 9.1%. Growing incidence of organ failure has resulted in massive growth in the transplantation market. Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost growth of the market during forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for management of organ failure.

Key Takeaways from the report: 

• Tissue products segment was the largest revenue-generating amongst others due to escalating number of tissue and organ transplant procedures

• Tissue products segment is also expected to grow at highest CAGR owing to advancement in transplantation products

• Tissue transplant segment held the largest revenue share in the market, because of rising number of skin, bones, heart valves, cornea, tendons, nerves, and veins procedures worldwide

• The transplant centers segment is projected to grow at the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures

• The hospitals segment dominated the market in terms of revenue in 2016 owing to a large number of transplant procedures performed in hospitals

• North America was the leading regional sector in 2016 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure

• Existence of large number of research laboratories, biotechnology, and medical device companies in the North America region is the major factor contributing to its large share

• Some of the major players include AbbVie, Inc.; Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; Stryker; 21st Century Medicine; BioLifeSolutions, Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals.

U.S. transplantation market, by product, 2014 – 2025 (USD billion)

Browse More Reports in Biotechnology Industry :

• Oncology based Molecular Diagnostics Market – Rising prevalence of various types of cancer such as breast, colorectal, and Non-Small Cell Lung Cancer (NSCLC) amongst the world population is the key driver propelling the growth of oncology based molecular diagnostics industry.

• Genomics In Cancer Care Market – Rising investments in biotech & pharmaceutical industry and increasing R&D activities for the development of novel treatment therapies are the factors attributing towards the growth of genomics in cancer care market

Germany transplantation market share, by application, 2016 (%)

Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products  and surgical instruments has majorly contributed to the expansion of the sector. In addition, introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment.  In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, availability of such advanced techniques supports increase in the number of organ transplant procedures.

 Competitive Insights

The transplantation market is highly fragmented with the presence of many large, small, and medium-scale vendors. Several leading players, such as AbbVie, Inc.; Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; Stryker; 21st Century Medicine; BioLifeSolutions, Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals share market with local vendors.

Leading players are involved in launching new products, mergers & acquisitions, and regional expansion to gain maximum revenue share in the industry. Mergers and acquisitions support vendors in expanding their existing product portfolio and geographical reach. For instance, in June 2015, Zimmer Holdings, Inc. announced the acquisition of Biomet to strengthen their product portfolio and distribution channels.

Rising regulatory approvals for allografts, autologous grafts, and other materials along with development of innovative products, such as 3D bioprinting, has led to high demand for transplant products. This 3D bioprinting can be used to regenerate tissues and organs. For instance, Organovo Holdings, Inc., a 3D biology company, announced in January 2014 that it completed its first 3D Liver tissue delivery.

Ask Our Industry Expert for more details on report- https://www.grandviewresearch.com/inquiry/4516/ibb

Regional Insights

In 2016, North America dominated the transplantation market and is expected to maintain its dominance throughout the study period. Well-developed healthcare facilities and local presence of many large biotechnology and medical devices companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker is supporting the market growth.

The gap between demand and supply of organs, including kidney, liver, and heart, for transplantation has increased in the last decade. However, governments and NGOs of various countries are taking initiatives to encourage people to donate organs and save lives. New guidelines and rules for organ donation make the donation process more transparent and easy. In 2013, the Australian Government conducted a national reform program to increase organ donation and transplant. This led to an increase in the number of organ donations from the previous year.

Asia Pacific market is projected to grow at the highest rate during the forecast period, owing to the growing research on stem cells to develop invitro tissue and organs as well as developing healthcare infrastructure in Asian countries such as India, Thailand, Philippines, Indonesia.

Grand View Research has segmented the global transplantation market on the basis of product, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2014 – 2025)

• Tissue products

• Immunosuppressive drugs

• Preservation solutions

Application Outlook (Revenue, USD Billion; 2014 – 2025)

• Organ transplantation

• Tissue transplantation

End-Use Outlook (Revenue, USD Billion; 2014 – 2025)

• Hospitals

• Transplant centers

• Others

Regional Outlook (Revenue, USD Billion; 2014 – 2025)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

• Asia Pacific

  • Japan

  • China

  • India

• Latin America

  • Brazil

  • Mexico

• MEA

• South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grad View Research, Inc.

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/transplantation-market